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Recent evidence suggests that generation of hydroxyl radicals in the presence of lipid
membranes can lead to oxidation of arachidonic acid esterified to glycerophospholipids and
the production of compounds isomeric to prostaglandins, thromboxanes, and leukotrienes.
Liquid chromatography tandem mass spectrometry and multiple reaction monitoring were
employed to quantitate the production of 5-hydroxyeicosatetraenoic acid (5-HETE), 5-hy-
droperoxyeicosatetraenoic acid (5-HPETE), and 5-oxo-eicosatetraenoic acid (5-oxo-ETE) in red
blood cells ghosts treated with t-butylhydroperoxide (tBuOOH). Untreated red blood cell
ghosts were found to contain low, but measurable quantities of these three 5-oxygenated
eicosanoids as phospholipid esters. Following treatment, there was approximately a 53- and
22.5-fold increase in 5-HETE and 5-HPETE, respectively, and an 8.5-fold increase in 5-oxo-ETE.
The formation of these compounds was inhibited nearly 90% by the antioxidants butylated
hydroxytoluene, ascorbic acid, and resveratrol providing further evidence for free radical
mediated oxidation of arachidonic acid. This analytical protocol provided sufficient sensitivity
for detection of these compounds in studies in which previous analysis by high-pressure liquid
chromatography with UV detection failed to detect their presence. These results reveal that the
biologically active eicosanoids 5-HETE, 5-HPETE, and 5-oxo-ETE are formed esterified to
phospholipids following exposure of cellular membranes to reactive oxygen species and free
radicals in a model system where intracellular antioxidant mechanisms were depleted. (J Am
Soc Mass Spectrom 1998, 9, 527–532) © 1998 American Society for Mass Spectrometry
Arachidonic acid is known to be oxidized byseveral enzymatic pathways including prosta-glandin H2 synthase [1], 5-lipoxygenase [2], and
cytochrome P-450 dependent epoxygenase reactions
[3]. These enzymatic pathways require free arachidonic
acid as substrate and result in a host of biologically
active lipid mediators including prostaglandins, throm-
boxanes, leukotrienes, and epoxyeicosatetraenoic acids.
These molecules are known to play important roles in
both intra and intercellular signaling events within cells
[4, 5]. Although considerable attention has been given
to the enzymatic production of prostaglandins and
leukotrienes, it is now clear that nonenzymatic path-
ways can lead to the formation of biologically active
metabolites of arachidonic acid. These pathways in-
volve the free radical oxidation of arachidonic acid
while it is esterified to glycerophospholipids. Com-
pounds, including isoprostanes [6], isothromboxanes
[7], and isoleukotrienes [8], have been found as prod-
ucts of both in vivo and in vitro arachidonoyl glycero-
phospholipid free radical oxidation.
Of particular interest is the fact that free radical
oxidation of esterified arachidonic acid can lead to the
production of biologically active products including
5-hydroperoxyeicosatetraenoic acid, 5-hydroxyeicosa-
tetraenoic acid, and 5-oxo-ETE. The first two com-
pounds, 5-HPETE and 5-HETE, are racemic at the
stereogenic carbon-5 position but still exert significant
biological activity [9, 10]. The 5-oxo-ETE product has
never been previously reported as a phospholipid ester
nor as a free radical product, but is known to exert
significant biological activity [11]. Although lipid per-
oxidation leads to a host of products derived from the
major polyunsaturated fatty acids, namely arachidonic
and linoleic acids, the most potent biologically active
compounds in terms of elevation of intracellular cal-
cium ion in the human neutrophil are those that have
been oxygenated at carbon-5 of arachidonate. We pre-
viously found that esterified 5-HETE was one of the
more abundant products formed following free radical
oxidation of intact red blood cells (RBC) by using
t-butylhydroperoxide (tBuOOH) to increase hydroper-
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oxide tone within lipid membranes [12]. These studies
suggested that 5-HPETE was initially formed as an
arachidonoyl ester that underwent subsequent reac-
tions including reduction to yield the observed 5-HETE.
Several pathways for hydroperoxide reduction includ-
ing glutathione, glutathione-S-transferase [13], and
phospholipid hydroperoxide glutathione peroxidase
[14] exist within cells that limit concentrations of ester-
ified 5-HPETE. The use of the RBC ghosts treated with
tBuOOH [15] has been used as a model to investigate
initial events of lipid peroxidation as well as a model for
cellular events that take place after exhaustion of anti-
oxidant defense mechanisms, which likely occurs as a
result of events such as chronic inflammation [16].
Measurement of the oxidized metabolites of arachi-
donic acid including 5-HETE, 5-HPETE, and 5-oxo-ETE
has been reported using several strategies. The most
widely used protocols are based upon high-pressure
liquid chromatography (HPLC) separation followed by
UV detection because these molecules have conjugated
double bonds with reasonably large extinction coeffi-
cients (23,000 5-HETE/5-HPETE at 236 nm and 19,600
at 279 nm for 5-oxo-ETE) [17–19]. Reverse phase HPLC
is typically used to separate these eicosanoids and
quantitation is possible when 5–10 ng is injected on
column [20]. In addition, gas chromatography/mass
spectrometry (GC/MS) techniques have been devel-
oped to analyze these compounds, but require prior
derivatization to render these molecules suitable for gas
phase analysis. These GC/MS methods also require the
reduction of the conjugated double bond system to
reduce the saddle effect observed during GC analysis
[21]. Nonetheless, when GC/MS is coupled with elec-
tron capture ionization, a sensitive assay for derivatized
5-HETE [14] and 5-oxo-ETE quantitation is possible [15,
22].
Direct analysis of fatty acid hydroperoxides is not
possible by GC/MS, which has limited the direct study
of 5-HPETE synthesis. With the development of electro-
spray ionization, LC/MS, and LC/MS/MS techniques,
it has become apparent that specific and direct assays
can be developed for hydroperoxides [23], which re-
quire less sample handling yet retain sufficient sensitiv-
ity, thus permitting quantitation of these important
products of free radical oxidation of arachidonic acid at
levels encountered during in vitro lipid peroxidation.
We have used this strategy to develop a direct mass
spectrometric assay for 5-HPETE and report here, for
the first time, the use of this assay in quantitating
production of this biologically active hydroperoxy eico-
sanoid.
Methods
Materials
Resveratrol, d8-5(S)-HETE, 5(S)-HETE, 5(S)-HPETE,
and 5-oxo-ETE were obtained from Cayman Chemical
(Ann Arbor, MI). The following chemicals were ob-
tained from Sigma Chemical Co. (St. Louis, MO): t-
butylhydroperoxide (tBuOOH), butylated hydroxytolu-
ene (BHT), and L-ascorbic acid. All solvents were HPLC
grade (Fisher, Fair Lawn, NJ).
Preparation of RBC Ghosts
Venous blood (30 mL) was taken from normal human
volunteers, treated with 3.8% sodium citrate (3.3 mL),
and within 60 min blood centrifuged at 300 3 g for 20
min to separate serum and buffy coat from RBC. The
cells were washed by resuspending them in 50-mL
phosphate buffer saline (PBS, 8.0-g NaCl; 0.20-g KCl;
1.51-g Na2HPO4; 1.16-g KH2PO4 dissolved in 1-L water
and adjusted to pH 7.4), then centrifuged at 760 3 g for
15 min to pellet the cells. A second wash in 50-mL PBS
was employed followed by a final centrifugation at
1700 3 g for 15 min to yielded packed RBCs.
RBC lysis was carried out according to the method of
Bratton [24] with several modifications. Briefly, aliquots
of packed RBC (500 mL) were placed in separate centri-
fuge tubes after resuspension in 6-mL cold lysis buffer
[PBS diluted fivefold, containing 1-mM MgCl2, 0.1-mM
egtazic acid (EGTA)] for 1 h on ice. Following lysis, the
suspension was spun at 26,000 3 g for 15 min, super-
natant discarded, and pellet resuspended in 6-mL wa-
ter. This suspension was then passed several times
through a 22-gauge syringe needle to insure lysis was
complete. The process of centrifugation and resuspen-
sion in distilled water was repeated 4–5 times to obtain
the substantially white RBC ghosts; however, traces of
hemoglobin were still present. The ghosts were resus-
pended in 1.7-fold concentrated PBS (4 mL) and sealed
by placing in a 37°C water bath for 30 min, then stored
at 4°C overnight. The ghosts were centrifuged at 1700 3
g for 15 min, lysed with distilled water on ice, resealed,
and pelleted by centrifugation (1700 3 g, 15 min)
immediately before incubation. Protein was measured
by the bicinchoninic acid protein assay [25].
Incubation with t-Butylhydroperoxide
Ghosts were incubated at a final concentration of 0.2-
mg/mL total protein and 10-mM tBuOOH for 90 min at
37°C. Identical aliquots of the ghost preparation were
incubated for 90 min at 37°C without addition of
tBuOOH as the control experiment for endogenous
lipid peroxidation products in the RBC ghost prepara-
tion. In separate experiments, RBC ghost preparations
were incubated with 1-mM BHT, 5-mM ascorbic acid, or
0.44-mM resveratrol for 1 min prior to the addition of
tBuOOH followed by a 90-min incubation at 37°C. Each
reaction was terminated by the addition of 5-mg BHT
dissolved in 1-mL methanol. This also inhibited any
further oxidation during the lipid extraction (see be-
low).
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Lipid Extraction and Saponification
Phospholipids were extracted from RBC ghosts essen-
tially by the method of Bligh and Dyer [26] substituting
methylene chloride for chloroform. The methylene chlo-
ride layer was removed, taken to dryness, then resus-
pended in 1.5-mL 85% methanol. Hydrolysis of the fatty
acyl groups was carried out at room temperature for 1 h
by the addition of 500-mL NaOH(1N). The reaction
mixture was acidified by the addition of 50-mL 88%
formic acid and the sample vacuum concentrated to
approximately 200 mL. The sample was then diluted to
1 mL with a final concentration of 30% B (see below).
The stable isotope labeled internal standard, d8-5(S)-
HETE (25 ng) was added to each sample at this point.
Reverse Phase HPLC/Mass Spectrometry
(RP-HPLC/MS)
An Ultremex 5-mm 4.6-mm 3 250-mm column (Phe-
nomenex, Torrance, CA) with an ODS Guard-pak pre-
column (Waters, Marlborough, MA) was used for sep-
aration of saponified fatty acyl groups. The solvent
system was as follows: Solvent A: 8.3-mM acetic acid
adjusted to pH 5.7 with ammonium hydroxide; solvent
B: methanol:acetonitrile (35:65). The flow rate was 1
mL/min with the following stepwise gradient: 30–55%
B over the first 10 min, 55–75% B over the next 15 min,
75–100% B over 5 min, then hold at 100% B. The effluent
was split postcolumn with 30% diverted to the mass
spectrometer and 1 mL of sample injected.
Electrospray Ionization Multiple Reaction
Monitoring (MRM) Mass Spectrometry
Mass spectrometry analysis was performed on a Sciex
API-III1 (PE-Sciex, Toronto, Canada) operated in the
negative ion mode with an orifice voltage of 255 V.
Curtain gas flow was 1.2 L/min, nebulizer pressure 40
lb/in.2, and ion spray voltage was 23500 V (nitrogen as
nebulizing gas). Product ion spectra were obtained
using a collision energy of 15 eV and collision gas
thickness (argon) of 211 3 1013 molecules/cm2.
Results
Electrospray ionization of 5-HETE, 5-HPETE, and
5-oxo-ETE results in the formation of an abundant
negative ion corresponding to the carboxylate anion
from each of these eicosanoids. Collision induced de-
composition of these carboxylate anions yields a large
number of decomposition ions, several of which carry
unique structural information as has been previously
investigated [23, 27]. For example, collision induced
decomposition of 5-HPETE (m/z 335) yields abundant
ions at m/z 203, 129, and 59. Collision induced decom-
position of the isobaric compound leukotriene B4 also
produces the same ions; however, they are substantially
less abundant compared to the major product ion at
m/z 195 [28]. Collision induced decomposition of the
5-oxo-ETE carboxylate anion (m/z 317) yields the same
ions observed for decomposition of the molecular anion
of 5-HPETE (m/z 335) because of a facile dehydration
reaction [23]. The orifice potential was reduced to 255
V to reduce the extent of this reaction prior to the first
quadrupole mass filter, but even at this voltage, the
dehydration ion was quite abundant. Collision induced
decomposition of 5-HETE (m/z 319) yields relatively
few decomposition ions, but they are quite abundant
and specific for this eicosanoid (m/z 203 and 115). It is
not unexpected that similar product ions are observed
for these compounds as they are members of a struc-
turally related family of molecules. Therefore, analysis
of these eicosanoids required separation prior to
MS/MS analysis and fortunately, all of these eico-
sanoids were readily separated by RP-HPLC.
Stable isotope labeled 5-HETE [25-ng, d8-5(S)-HETE]
was employed as internal standard for the assay with
the following specific ion transitions monitored: m/z
327 3 m/z 210 for d8-5(S)-HETE; m/z 319 3 m/z
203 for 5-HETE; m/z 335 3 m/z 203 for 5-HPETE;
m/z 317 3 m/z 203 for 5-oxo-ETE (Figure 1). The
d8-5(S)-HETE also served as a marker for HPLC reten-
tion time. Typical calibration curves (Figure 1) for all
compounds studied showed excellent linearity in the
range of 1–350 ng of oxidized arachidonic acid using 25
ng of d8-5(S)-HETE as internal standard. The detection
limits for this protocol were assessed in separate exper-
iments and a signal-to-noise ratio greater than 3 was
observed when 1 ng was injected onto the column for
5-HETE and 5-HPETE and 300 pg injected onto the
column for 5-oxo-ETE.
The quantitative assay for these 5-oxygenated eico-
sanoids was used to investigate whether these com-
pounds were present in the normal plasma membrane
preparation from red blood cells and if an agent that
increased membrane peroxide tone [15] would induce
Figure 1. MRM standard curves. Solutions were prepared con-
taining authentic standards of 5(S)-HETE, 5(S)-HPETE, and
5-oxo-ETE and analyzed by MRM LC/MS/MS as described in
Methods. Amounts ranging from 1.4 to 350 ng were used for
5(S)-HETE, 1.3–334 ng for 5(S)-HPETE, and 1.1–29 ng for 5-oxo-
ETE, as well as samples with no target eicosanoid added, with the
following ion transitions monitored: m/z 319 3 203, m/z 335 3
203, and m/z 3173 203. The d8-5(S)-HETE internal standard (25
ng) was monitored as the ion transition m/z 327 3 210. The
MRM ratio was calculated as the ratio of the abundance of target
eicosanoid ion transition to that of the abundance of the internal
standard ion transition.
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their synthesis. Treatment of RBC ghosts for 90 min at
37°C with tBuOOH (10 mM) resulted in the formation
of abundant oxidized arachidonic acid and specifically
5-HPETE, 5-HETE, and to a lesser extent 5-oxo-ETE as
revealed by a representative LC/MS/MS trace for these
components (Figure 2). The specific formation of
5-HETE was observed at 25.8 min from the transition
m/z 319 3 203, although other monohydroxyeicosa-
tetraenoic acids were also formed in this reaction as
revealed by the components eluting at 23.6 and 24.7 min
which yielded m/z 203 as a minor product ion from
decomposition of m/z 319. Six different monohy-
droxyeicosatetraenoic acid isomers were possible in the
free radical oxidation of arachidonic acid, but their
formation was not further investigated.
The second most abundant 5-oxygenated eicosanoid
corresponded to 5-HPETE, which was detected by the
specific transition m/z 335 3 m/z 203 at 26.6 min.
Other monohydroperoxy eicosanoids were also likely
present (isobaric at m/z 335), however, only minor
product ions at m/z 203 were formed by these prod-
ucts, which also elute at a different retention time. This
chemically reactive hydroperoxide would be the imme-
diate precursor of 5-HETE and was likely an initial
oxidized product of the reaction of molecular oxygen
with arachidonate esterified to glycerophospholipids in
the RBC ghosts. The least abundant 5-oxygenated eico-
sanoid corresponded to 5-oxo-ETE, which eluted at
approximately 26.9 min. The elution of this component
was also characterized by significant absorption at 280
nm characteristic for a conjugated dienone in 5-oxo-ETE
(data not shown). The transition m/z 317 3 m/z 203
also indicated the elution of 5-HPETE at 26.6 min, as
m/z 317 is a facile dehydration product ion of 5-HPETE
formed during the electrospray ionization process [23].
Untreated RBC ghosts were found to contain both
5-HPETE and 5-HETE and a substantially lower quan-
tity of 5-oxo-ETE. Following the treatment of RBC
ghosts, a striking increase in 5-HETE, 5-HPETE, and to
a lesser extent 5-oxo-ETE was observed (Table 1). Sev-
eral antioxidants were employed to address whether or
not 5-HETE production could be inhibited in this lipid
peroxidation model. Butylated hydroxytoluene (1 mM),
ascorbic acid (5 mM), and resveratrol (0.44 mM), a
natural product isolated from grapes [29] were added to
the isolated RBC ghosts immediately prior to the addi-
tion of the tBuOOH. The 5-oxygenated eicosanoids
were then analyzed using the LC/MS/MS protocol
(Figure 3). The production of all of these oxygenated
eicosanoids was found to decrease dramatically. The
quantity of oxidized metabolites found in the resvera-
trol treated RBC ghosts was indistinguishable from
levels of 5-HETE and 5-HPETE initially present in
untreated RBC ghosts.
Discussion
Electrospray ionization mass spectrometry has enabled
development of a sensitive and specific quantitative
assay for the eicosanoid, 5-HPETE. This assay was used
to investigate whether or not 5-HPETE was a major
product of lipid peroxidation involving red blood cell
Figure 2. MRM LC/MS/MS chromatogram from tBuOOH
treated RBC ghosts. Representative chromatogram of target eico-
sanoids produced after tBuOOH (10 mM) treatment of RBC ghosts
(0.2-mg protein). (A) The ion transition m/z 327 3 210 [d8-5(S)-
HETE] was used to normalize the MRM signals for target eico-
sanoids in (B), (C), and (D). (B) Ion transition m/z 319 3 203
used for MRM analysis of 5-HETE. (C) Ion transition m/z 317 3
203 used for MRM analysis of 5-oxo-ETE. (D) Ion transition m/z
335 3 203 used for MRM analysis of 5-HPETE.
Table 1. Quantitation of 5-oxygenated arachidonate esterified
to phospholipids in the plasma membrane of red blood cells
(RBC ghosts) before and after treatment with
t-butylhydroperoxide
5-HETE 5-HPETE 5-Oxo-ETE
Control RBC 4.7 6 2.3 8.5 6 6.0 1.8 6 1.8
tBuOOH (10 mM) 264 6 140 191 6 116 17.1 6 1.8
Figure 3. MRM quantitation. Amount of 5-HETE (filled square),
5-HPETE (open square), and 5-oxo-ETE (lined square) quantitated
by MRM analysis after treatment of RBC ghosts for 90 min at 37°C
with tBuOOH (10 mM) alone or with tBuOOH (10 mM) in
addition to the following antioxidants: ascorbic acid (5 mM),
resveratrol (0.44 mM), and BHT (1 mM). Control RBC ghosts were
incubated under identical conditions for 90 min at 37°C with no
addition of tBuOOH or antioxidants. Results are averages of 3
samples from different donors 6 SEM and have been normalized
by the amount of total protein (0.2 mg) in the incubation.
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ghosts. This model of lipid peroxidation of cellular
plasma membranes focuses attention on peroxidative
events that take place in cells with little antioxidant
defense mechanisms [15]. Such antioxidant mechanisms
are responsible for the chemical reduction of this chem-
ically reactive, yet biologically active hydroperoxide.
This mass spectrometric approach was also used to
quantitate 5-HETE and 5-oxo-ETE, in addition to the
5-HPETE, by RP-HPLC/tandem mass spectrometry op-
erating in the MRM mode. This was an attractive alterna-
tive to other methods of analysis of these eicosanoids such
as RP-HPLC with ultraviolet detection and GC/MS. Al-
though GC/MS based protocols can be used to quantitate
the biologically active 5-HETE and 5-oxo-ETE, it is not
compatible with the analysis of 5-HPETE.
The LC/MS/MS method described here had detec-
tion limits in the picogram to low nanogram level
(injected quantity) permitting investigations of in vitro
production of this reactive eicosanoid in phospholipid
precursors. Significantly enhanced sensitivity would be
expected if smaller diameter HPLC columns were em-
ployed with corresponding lower flow rates that would
increase analyte concentrations in the effluent. The
assay described here utilized only 30% of the effluent
for MS/MS analysis permitting collection of the remain-
ing effluent. Nevertheless, the sensitivity of this LC/
MS/MS assay permitted accurate determination of each
of these free radical derived metabolites from RBC
ghosts when formation of these metabolites was inhib-
ited greater than 90%. By using the RP-HPLC assay
with a UV monitor, it was not possible to detect the
occurrence of 5-HETE, 5-HPETE, or 5-oxo-ETE present
in unstimulated RBC ghosts. Sufficient sensitivity was
available in this electrospray mass spectrometric assay
to permit detection of these components present in
unstimulated RBC ghosts. Of further advantage was the
minimal sample handling required prior to the mass
spectrometric assay when compared to a GC/MS based
assay. In large part, this was made possible because of
formation of abundant carboxylate anions during elec-
trospray ionization of the nonderivatized carboxylic
acid. A reduced orifice potential was employed in this
assay to lessen the dehydration ions [M–H2O]
2 and
correspondingly increase the sensitivity of this assay.
The esterification of 5-HETE into glycerophospholip-
ids has been previously examined and found to be a
facile process for 5-lipoxygenase generated 5(S)-HETE
[30]. However, studies reported here show that esteri-
fied 5-HETE, and in particular esterified 5-HPETE, can
be found in relatively high levels as a result of free
radical oxidation of arachidonate in situ. There have
been no previous reports of esterified 5-HPETE in
phospholipids. The use of the RBC ghost model elimi-
nated the possibility that the observed esterified
5-HETE and 5-HPETE were derived from a reacylation
mechanism from the corresponding free acids. First,
5-lipoxygenase is not present in the intact RBC or RBC
ghost. Furthermore, the RBC ghost is depleted of the
cofactors necessary for the formation of CoA ester of
5-HETE or 5-HPETE required for the reacylation mech-
anism. Thus, the observed 5-HETE and 5-HPETE glyc-
erophospholipids were a result of direct lipid peroxida-
tion and not an indirect effect of enzymatic formation of
these molecules in this model system.
In the present study, oxidized arachidonic acid was
found to be present at fairly low levels as evidenced by
the abundance of 5-HETE, 5-HPETE, and 5-oxo-ETE in
normal RBC ghosts. These three lipid peroxidation
products increased significantly following treatment
with tBuOOH. Due to the highly reactive nature of the
free radical species involved during lipid peroxidation,
it would be expected that variation in the observed
quantity of these oxidized products may result as was
observed (Table 1). We have previously found the
formation of 5-HETE in tBuOOH treated intact RBC
along with formation of the isobaric epoxyeicosatrie-
noic acids (EET) [12]. Specific analysis of EET esters was
not investigated in this model system. Although the
intermediacy of esterified 5-HPETE was suggested in
these previous studies, the presence of numerous anti-
oxidant mechanisms and high intracellular concentra-
tion of glutathione in the intact RBC led to a rapid
reduction of phospholipid hydroperoxides to phospho-
lipid alcohols. The RBC ghost has been used to model
those situations in vivo when such antioxidant mecha-
nisms are absent or substantially reduced [15].
The nonenzymatic nature of lipid peroxidation in-
duced by tBuOOH was supported by the observed
inhibition of product formation using the antioxidant
compounds BHT, ascorbic acid, and resveratrol. Res-
veratrol, 3,5,49-trihydroxy-trans-stilbene, is a natural
product isolated from grapes, which has been found to
possess chemopreventive activity in each of the stages
of carcinogenesis initiation, promotion, and propaga-
tion [29]. Furthermore, resveratrol has been shown to
possess antioxidant properties as demonstrated by the
inhibition of TPA induced free radical formation in
human promyelocytic leukemia cells [29]. Resveratrol, as
well as ascorbic acid and BHT, were capable of inhibiting
the formation of 5-HETE, 5-HPETE, and 5-oxo-ETE, fur-
ther demonstrating potential of resveratrol as a lipid
antioxidant. The MRM assay had sufficient sensitivity and
precision to determine inhibition of the formation of these
oxidized arachidonic acid isomers at levels greater than
75% and to levels observed of esterified 5-oxygenated
eicosanoids in untreated RBC ghosts.
Formation of these phospholipid products of ara-
chidonate free radical oxidation is of interest from
several points of view. Such molecules can serve as
markers of free radical oxidation of biological mem-
branes since monohydroperoxides are likely the ini-
tially formed products of the reaction between phos-
pholipid radical species with molecular oxygen [31].
However, these compound can be derived from 5-li-
poxygenase catalyzed mechanisms, which limits their
value as unique markers. Nevertheless, detection of
5-HPETE suggests limited or diminished antioxidant
defense mechanisms. More interestingly, the targets of
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this study, 5-oxo-ETE, 5-HPETE, and 5-HETE are
known to exert potent biological activities on different
tissues. Natural killer cell mediated cytotoxicity has
been found to be enhanced by 5-HPETE [32] as well as
eosinophil and neutrophil chemotaxis [33]. Racemic
5-HPETE has also been found to be a potent agonist of
neutrophil degranulation [34]. Pharmacologic studies
have shown both 5(S)-HETE and 5-oxo-ETE to increase
intracellular calcium ion in the human polymorphonu-
clear leukocytes in a dose dependent manner [35, 36].
The 5(R)-HETE isomer was found to be substantially
less potent in this biological assay. The most potent
activities for these class of molecules has been reported
for 5-oxo-ETE. The degranulation of the human neutro-
phil was also found to be stimulated by 5-oxo-ETE in
conjunction with GM-CSF or G-CSF in substantially
lower concentrations than that required for other mo-
nooxygenated products of arachidonic acid [37]. 5-Oxo-
ETE has also been shown to increase O2
2 anion produc-
tion in neutrophils [37] and a considerable amount of
interest has focused on the activities of 5-oxo-ETE
because of its potency as a chemotactic agent for the
human eosinophil [38].
Further reactions of these free radical products are
also possible; for example, 5-HPETE is readily degraded
enzymatically by peroxidases [39] or nonenzymatically
through reaction with heavy metals [31], to 5-HETE.
Dehydration of 5-HPETE to 5-oxo-ETE can take place
by nonenzymatic mechanisms. Oxidation of 5-HETE to
5-oxo-ETE is known to be catalyzed by the enzyme
5-hydroxyeicosanoid dehydrogenase [22]. Interestingly,
5-HPETE can be converted into the leukotriene precur-
sor LTA4 by 15-lipoxygenase [40].
Because the biological activities of 5-HETE and
5-HPETE, as well as isoprostanes and isoleukotrienes,
were studied as the corresponding free acids, mecha-
nisms responsible for liberation of the oxidized arachi-
donoyl ester from the phospholipid have become of
interest. New evidence has emerged for specific phos-
pholipases that can rapidly hydrolyze oxidized fatty
acyl esters from phospholipids. These enzymes include
calcium-dependent phospholipase A2 [41] and platelet
activating factor acetyl hydrolase [42]. The assay re-
ported here can be used to independently assess hydro-
lysis of esterified 5-HETE and 5-HPETE.
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